Dynamics of anti-SARS-CoV-2 seroconversion in individual patients and at the population level.

ABSTRACT: The immune response and specific antibody production in COVID-19 are among the key factors that determine both prognostics for individual patients and the global perspective for controlling the pandemics. So called "dark figure", that is, a part of population that has been infected but not registered by the health care system, make it difficult to estimate herd immunity and to predict pandemic trajectories. Here we present a follow up study of population screening for hidden herd immunity to SARS-CoV-2 in individuals who had never been positively diagnosed against SARS-CoV-2; the first screening was in May 2021, and the follow up in December 2021. We found that specific antibodies targeting SARS-CoV-2 detected in May as the "dark figure" cannot be considered important 7 months later due to

SUBMITTER: Szewczyk-Dabrowska A 

PROVIDER: S-EPMC9462561 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature